Skip to main content

Table 1 Demographical data of 71 patients with mucinous carcinoma of the breast

From: Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma

Parameters(n=71) Percentage
Age mean 61.8 (26 – 95, median 64)
Tumor diameter (cm) mean 3.1 (0.5 – 12.3, median 2.5)
Tumor location 39 (54.9%)/32 (45.1%)
     right/left  
Subtype 23 (32.4%)/32 (45.1%)/16 (22.5%)
     MMBC/PMBC-A / PMBC-B  
Pathological stage 23 (32.4%)/40 (56.3%)/8 (11.3%)
     I/II/III  
pT 23 (32.4%)/38 (53.5%)/6 (8.5%)/ 4 (5.6%)
     T1/T2/T3/T4  
pLymph node status 8 (11.3%)/63 (88.7%)
     Positive/Negative  
Lymphovascular invasion 15 (21.1%)/56 (78.9%)
     Positive/Negative  
Nuclear grade 55 (77.5%)/15 (21.1%)/1 (1.4%)
     1/2/3  
EIC 31 (43.7%)/40 (56.3%)
     Positive/Negative  
Hormone receptor status 68 (95.8%)/3 (4.2%)
     Positive/Negative  
HER 2 status 1 (1.4%)/70 (98.6%)
     Positive/Negative  
Ki67 8 (11.3%)/63 (88.7%)
     Positive/Negative  
Recurrence 7 (9.9%)/64 (90.1%)
     Recurrence/no- Recurrence  
Recurrence cases (n=7) 6 (85.7%)/0 (0.0%)/1 (14.3%)
     MMBC/PMBC-A/PMBC-B  
  1. MMBC mixed mucinous carcinoma, PMBC pure mucinous carcinoma, EIC extensive intraductal component.